298 related articles for article (PubMed ID: 9452426)
1. Cytochrome b5 augments the 17,20-lyase activity of human P450c17 without direct electron transfer.
Auchus RJ; Lee TC; Miller WL
J Biol Chem; 1998 Feb; 273(6):3158-65. PubMed ID: 9452426
[TBL] [Abstract][Full Text] [Related]
2. P450c17 mutations R347H and R358Q selectively disrupt 17,20-lyase activity by disrupting interactions with P450 oxidoreductase and cytochrome b5.
Geller DH; Auchus RJ; Miller WL
Mol Endocrinol; 1999 Jan; 13(1):167-75. PubMed ID: 9892022
[TBL] [Abstract][Full Text] [Related]
3. Regulation of 17,20 lyase activity by cytochrome b5 and by serine phosphorylation of P450c17.
Pandey AV; Miller WL
J Biol Chem; 2005 Apr; 280(14):13265-71. PubMed ID: 15687493
[TBL] [Abstract][Full Text] [Related]
4. Biochemical differences between rat and human cytochrome P450c17 support the different steroidogenic needs of these two species.
Brock BJ; Waterman MR
Biochemistry; 1999 Feb; 38(5):1598-606. PubMed ID: 9931027
[TBL] [Abstract][Full Text] [Related]
5. Human cytochrome b5 requires residues E48 and E49 to stimulate the 17,20-lyase activity of cytochrome P450c17.
Naffin-Olivos JL; Auchus RJ
Biochemistry; 2006 Jan; 45(3):755-62. PubMed ID: 16411751
[TBL] [Abstract][Full Text] [Related]
6. The developmental increase in adrenocortical 17,20-lyase activity (biochemical adrenarche) is driven primarily by increasing cytochrome b5 in neonatal rhesus macaques.
Nguyen AD; Corbin CJ; Pattison JC; Bird IM; Conley AJ
Endocrinology; 2009 Apr; 150(4):1748-56. PubMed ID: 19036885
[TBL] [Abstract][Full Text] [Related]
7. A Homodimer Model Can Resolve the Conundrum as to How Cytochrome P450 Oxidoreductase and Cytochrome b5 Compete for the Same Binding Site on Cytochrome P450c17.
Holien JK; Parker MW; Conley AJ; Corbin CJ; Rodgers RJ; Martin LL
Curr Protein Pept Sci; 2017; 18(5):515-521. PubMed ID: 28000554
[TBL] [Abstract][Full Text] [Related]
8. The molecular basis of isolated 17,20 lyase deficiency.
Miller WL; Geller DH; Auchus RJ
Endocr Res; 1998; 24(3-4):817-25. PubMed ID: 9888582
[TBL] [Abstract][Full Text] [Related]
9. NADPH-flavodoxin reductase and flavodoxin from Escherichia coli: characteristics as a soluble microsomal P450 reductase.
Jenkins CM; Waterman MR
Biochemistry; 1998 Apr; 37(17):6106-13. PubMed ID: 9558349
[TBL] [Abstract][Full Text] [Related]
10. Assessment of the ability of type 2 cytochrome b5 to modulate 17,20-lyase activity of human P450c17.
Soucy P; Luu-The V
J Steroid Biochem Mol Biol; 2002 Jan; 80(1):71-5. PubMed ID: 11867265
[TBL] [Abstract][Full Text] [Related]
11. Role of cytochrome b5 in the modulation of the enzymatic activities of cytochrome P450 17α-hydroxylase/17,20-lyase (P450 17A1).
Bhatt MR; Khatri Y; Rodgers RJ; Martin LL
J Steroid Biochem Mol Biol; 2017 Jun; 170():2-18. PubMed ID: 26976652
[TBL] [Abstract][Full Text] [Related]
12. The primate adrenal zona reticularis is defined by expression of cytochrome b5, 17alpha-hydroxylase/17,20-lyase cytochrome P450 (P450c17) and NADPH-cytochrome P450 reductase (reductase) but not 3beta-hydroxysteroid dehydrogenase/delta5-4 isomerase (3beta-HSD).
Mapes S; Corbin CJ; Tarantal A; Conley A
J Clin Endocrinol Metab; 1999 Sep; 84(9):3382-5. PubMed ID: 10487714
[TBL] [Abstract][Full Text] [Related]
13. Phosphorylation of human cytochrome P450c17 by p38α selectively increases 17,20 lyase activity and androgen biosynthesis.
Tee MK; Miller WL
J Biol Chem; 2013 Aug; 288(33):23903-13. PubMed ID: 23836902
[TBL] [Abstract][Full Text] [Related]
14. The post-translational regulation of 17,20 lyase activity.
Miller WL; Tee MK
Mol Cell Endocrinol; 2015 Jun; 408():99-106. PubMed ID: 25224484
[TBL] [Abstract][Full Text] [Related]
15. The 17, 20-lyase activity of cytochrome p450c17 from human fetal testis favors the delta5 steroidogenic pathway.
Flück CE; Miller WL; Auchus RJ
J Clin Endocrinol Metab; 2003 Aug; 88(8):3762-6. PubMed ID: 12915666
[TBL] [Abstract][Full Text] [Related]
16. Steroid 17 alpha-hydroxylase and 17,20-lyase activities of P450c17: contributions of serine106 and P450 reductase.
Lin D; Black SM; Nagahama Y; Miller WL
Endocrinology; 1993 Jun; 132(6):2498-506. PubMed ID: 8504753
[TBL] [Abstract][Full Text] [Related]
17. Cytochrome P450c17 from porcine and bovine adrenal catalyses the formation of 5,16-androstadien-3 beta-ol from pregnenolone in the presence of cytochrome b5.
Meadus WJ; Mason JI; Squires EJ
J Steroid Biochem Mol Biol; 1993 Nov; 46(5):565-72. PubMed ID: 8240978
[TBL] [Abstract][Full Text] [Related]
18. Molecular modeling of human P450c17 (17alpha-hydroxylase/17,20-lyase): insights into reaction mechanisms and effects of mutations.
Auchus RJ; Miller WL
Mol Endocrinol; 1999 Jul; 13(7):1169-82. PubMed ID: 10406467
[TBL] [Abstract][Full Text] [Related]
19. The cationic charges on Arg347, Arg358 and Arg449 of human cytochrome P450c17 (CYP17) are essential for the enzyme's cytochrome b5-dependent acyl-carbon cleavage activities.
Lee-Robichaud P; Akhtar ME; Wright JN; Sheikh QI; Akhtar M
J Steroid Biochem Mol Biol; 2004 Oct; 92(3):119-30. PubMed ID: 15555906
[TBL] [Abstract][Full Text] [Related]
20. Pitfalls in characterizing P450c17 mutations associated with isolated 17,20-lyase deficiency.
Gupta MK; Geller DH; Auchus RJ
J Clin Endocrinol Metab; 2001 Sep; 86(9):4416-23. PubMed ID: 11549685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]